RE-LY Study Shows Following Warfarin’s Adjustment Algorithm Improves INR in the TTR of AF Patients
According to a report based on the RE-LY trial which was published online October 1, 2012 in Circulation, following the recommended dose of Warfarin can dramatically improve an AF patient’s...
Colchicine May Lessen Early AF Recurrences
According to a new study that was published online October 3, 2012 in the Journal of the American College of Cardiology, giving colchicine to AF patients who have undergone pulmonary...
AF Patients Should be on Alert Despite Dabigatran’s Recent Success
Even though dabigatran has been prescribed as an AF treatment by 19 percent of doctors across the U.S., patients should still be wary of the drug and its bleeding risks,...
Dabigatran Use for Treating AF Growing
The newest AF treatment for stroke prevention — Dabigatran — is quickly gaining ground over other medications, including the extremely popular Warfarin. In fact, by the end of 2011, Dabigatran...
Even with Dabigatran’s Approval, People Still Undertreated for AF
When the new anticoagulant medication Dabigatran was approved recently as an AF stroke prevention treatment, it was quickly picked up for immediate use on patients. However, even with all of...